Abstract

Hyperpolarized contrast agents (HyCAs) have enabled unprecedented magnetic resonance imaging (MRI) of metabolism and pH in vivo. Producing HyCAs with currently available methods, however, is typically time and cost intensive. Here, we show virtually-continuous production of HyCAs using parahydrogen-induced polarization (PHIP), without stand-alone polarizer, but using a system integrated in an MRI instead. Polarization of ≈2% for [1-13C]succinate-d2 or ≈19% for hydroxyethyl-[1-13C]propionate-d3 was created every 15 s, for which fast, effective, and well-synchronized cycling of chemicals and reactions in conjunction with efficient spin-order transfer was key. We addressed these challenges using a dedicated, high-pressure, high-temperature reactor with integrated water-based heating and a setup operated via the MRI pulse program. As PHIP of several biologically relevant HyCAs has recently been described, this Rapid-PHIP technique promises fast preclinical studies, repeated administration or continuous infusion within a single lifetime of the agent, as well as a prolonged window for observation with signal averaging and dynamic monitoring of metabolic alterations.

Magnetic resonance imaging of hyperpolarized contrast agents has enabled unprecedented imaging capabilities in a biomedical setting, but its widespread application is hindered by the time and costs associated with preparing hyperpolarized carbon-13 samples. Here, the authors demonstrate virtually-continuous production of batches of highly-hyperpolarized carbon-13 contrast agents every 15 s within an MRI system without a stand-alone polarizer.

Details

Title
Quasi-continuous production of highly hyperpolarized carbon-13 contrast agents every 15 seconds within an MRI system
Author
Schmidt, Andreas B 1   VIAFID ORCID Logo  ; Zimmermann Mirko 2 ; Berner, Stephan 3 ; de Maissin Henri 3   VIAFID ORCID Logo  ; Müller, Christoph A 3   VIAFID ORCID Logo  ; Ivantaev Vladislav 2 ; Hennig Jürgen 2 ; Elverfeldt, Dominik v 2   VIAFID ORCID Logo  ; Jan-Bernd, Hövener 4   VIAFID ORCID Logo 

 University of Freiburg, Department of Radiology, Medical Physics, Medical Center, Faculty of Freiburg, Freiburg, Germany (GRID:grid.5963.9); German Cancer Consortium (DKTK), partner site Freiburg and German Cancer Research Center (DKFZ), Heidelberg, Germany (GRID:grid.7497.d) (ISNI:0000 0004 0492 0584); University Medical Center Schleswig-Holstein, Kiel University, Section Biomedical Imaging, Molecular Imaging North Competence Center (MOIN CC), Department of Radiology and Neuroradiology, Kiel, Germany (GRID:grid.412468.d) (ISNI:0000 0004 0646 2097) 
 University of Freiburg, Department of Radiology, Medical Physics, Medical Center, Faculty of Freiburg, Freiburg, Germany (GRID:grid.5963.9) 
 University of Freiburg, Department of Radiology, Medical Physics, Medical Center, Faculty of Freiburg, Freiburg, Germany (GRID:grid.5963.9); German Cancer Consortium (DKTK), partner site Freiburg and German Cancer Research Center (DKFZ), Heidelberg, Germany (GRID:grid.7497.d) (ISNI:0000 0004 0492 0584) 
 University Medical Center Schleswig-Holstein, Kiel University, Section Biomedical Imaging, Molecular Imaging North Competence Center (MOIN CC), Department of Radiology and Neuroradiology, Kiel, Germany (GRID:grid.412468.d) (ISNI:0000 0004 0646 2097) 
Publication year
2022
Publication date
2022
Publisher
Nature Publishing Group
e-ISSN
23993669
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2630424344
Copyright
© The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.